Sangamo’s hemophilia A gene therapy giroctocogene fitelparvovec, now overseen by Pfizer, leads a pipeline of 17 wholly-owned and partnered genomic medicines—four in clinical phases; the rest, preclinical . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge